5. – 6. May 2025 I Public Event
Swiss Biotech Day | Basel
SaxoCell will establish a lighthouse for cell and gene therapies in Saxony, featuring high international visibility. Here you will find a selection of news and information about our cluster. We are looking forward to press and media inquiries. Please contact us!
5. – 6. May 2025 I Public Event
Swiss Biotech Day | Basel
30. April 2025 I Public Event
Fuck-Up Night | Dresden
28. – 30. April 2025 I Public Event
LSX Leaders | London
15. April 2025 I Public Event
GeneNovate Workshop #4
9. – 10. April 2025 I Public Event
German Biotechnology Days
31. March 2025 I Public Event
GSCN on Tour in Leipzig – SaxoCell in Action!
10. – 11. March 2025 I Meeting
DG-GT Annual Meeting: Genome editing towards therapies
20. – 21. January 2025 | Meeting
SaxoCell Kickoff Meeting – 2nd Funding Phase
04. January 2025 | Publication
THE LANCET Paper from the Cluster
06. December 2024 | Workshop
Workshop on Automation in Dresden
03. December 2024 | Press Release
SaxoCell in Handelsblatt
26. November 2024 | Public Event
8th Life Science Forum
24. October 2024 | Public Event
Finance Day Celebrates Premiere in Leipzig
Finance Day Celebrates Premiere in Leipzig – Successful Networking of Life-Science Start-ups and Investors
The Finance Day, one of the most important events for start-up, growth, and capital market financing in the life sciences industry for the past 18 years, has opened a new chapter this year: for the first time, the prestigious event was held in Leipzig.
Organized by GoingPublic Media and the Plattform Life Sciences, the Finance Day provided an inspiring platform for promising life science projects and start-ups. In the unique atmosphere of BioCity Leipzig, innovative companies showcased themselves to renowned investors from across Germany.
Particularly notable were the contributions from the SaxoCell Future Cluster, including companies like Seamless Therapeutics, Katana Labs, and Singleron, which presented their groundbreaking technologies and business models. Ulrike Köhl, Cluster spokesperson of SaxoCell, took the opportunity to introduce the future cluster and other partner companies such as Cancilico, T-Cell Tolerance, and T-Curx to a wide audience.
In addition to the exciting pitches from the start-ups, networking and personal exchange were also at the heart of the event. The concluding evening event provided an ideal setting to forge new connections and further deepen the synergies within the industry.
With the first Finance Day in Leipzig, it was impressively demonstrated that the region is becoming a growing hub for innovation and collaboration in life sciences.
For 18 years, the Finance Day has been bringing together companies, investors, and industry experts from the life sciences sector. The goal of the event is to provide founders and start-ups with access to capital providers and thereby promote the development of innovative projects and technologies.
Precision Medicine in Focus: Successful 8th Life Science Forum Leipzig brings Science and Industry Together
At the end of November, the 8th Life Science Forum Leipzig took place, bringing together over 80 participants from science and industry to discuss the latest developments and perspectives in precision medicine. Organized jointly by Wirtschaftsförderung Sachsen (WFS) and the SaxoCell Cluster for Future, the event impressively demonstrated the importance of dialogue between research and business for progress in medical precision technology.
Following the opening by Uwe Lienig (WFS) and Stefanie Binder (SaxoCell), participants enjoyed a diverse program featuring high-profile presentations. Highlights included inspiring keynotes by Prof. Dr. Martin Bornhäuser (University Hospital Dresden), Dr. Maximilian Merz (University Hospital Leipzig), and Dr. Thorsten Pisch (Gilead Sciences), offering fascinating insights into the latest advancements and challenges in precision medicine. The program was further enriched by presentations on innovative approaches in diagnostics and therapy, emphasizing practical solutions for the healthcare of the future.
A particularly positive aspect was the active participation of numerous companies from saxony, including Seamless Therapeutics, Cancilico, T Cell Tolerance, DKMS Life Science Lab, and MDTB Cells. These contributions highlight Saxony’s outstanding position as a hub for innovative developments in the life sciences industry.
The venue, BioCity Leipzig, provided the perfect setting for a successful day filled with in-depth discussions, networking, and knowledge exchange. “The Life Science Forum Leipzig has once again proven how essential this regular exchange is for the advancement of precision medicine,” summarized Stefanie Binder from SaxoCell.
The Life Science Forum regularly brings together experts from science and industry to discuss key topics in life sciences and biotechnology. With a focus on current challenges and innovations, the forum serves as a platform for interdisciplinary exchange and networking within the industry.
“Saxony is one of the most exciting life sciences regions in Germany” – Thomas Horn in conversation
Saxony is increasingly establishing itself as a leading region for innovations in the life sciences sector. In an interview with Handelsblatt on December 3, 2024, Thomas Horn, Managing Director of Wirtschaftsförderung Sachsen GmbH (WFS), emphasized the region’s outstanding development and future prospects.
“Saxony is one of the most exciting life sciences regions in Germany,” Horn stated in the discussion. He particularly highlighted the Free State Dresden’s growing significance as a hub for cell and gene therapy, one of the most promising advancements in the healthcare sector.
With innovation clusters like the Cluster4Future SaxoCell and close collaboration between research institutions, universities, and companies, Saxony offers a unique ecosystem for groundbreaking developments in diagnostics and therapy. “We see strong momentum in the region, which excites both scientists and investors,” Horn emphasized.
Supported by targeted funding programs and excellent infrastructure, Saxony is attracting more and more start-ups and established companies from the life sciences sector. Facilities such as BioCity Leipzig and the Fraunhofer Institute for Cell Therapy and Immunology (IZI) serve as key hubs for networking and advancing innovation.
In addition to its economic and scientific achievements, Horn also praised the region’s international reach. “Saxony is increasingly positioning itself as a global player in the life sciences industry,” he said.
With this positive development, Saxony reinforces its ambition to take a leading role in one of the most important future fields of medicine.
The Wirtschaftsförderung Sachsen GmbH supports companies, investors, and research institutions in realizing their projects in the Free State of Saxony. With a focus on industries such as life sciences, mechanical engineering, and electromobility, WFS actively contributes to the region’s economic growth.
https://www.handelsblatt.com/adv/firmen/wirtschaftsfoerderung-sachsen-gmbh.html
Successful Workshop on Automation in Cell and Gene Therapy: SaxoCell Sets Important Impulses
On December 6, 2024, a groundbreaking workshop titled “Automated Production for Cell and Gene Therapy” took place at the DKMS Life Science Lab. Organized by SaxoCell in collaboration with Wirtschaftsförderung Sachsen (WFS) and VE.MAS innovativ, the event brought together leading experts in cell and gene therapy as well as Saxon providers of automation solutions.
The goal of the workshop was to identify the potential of automation in cell and gene therapy and to develop new approaches to make the industry more efficient and future-ready. The discussions were so engaging that they extended well beyond the scheduled time. “The enthusiasm and commitment of all participants showed just how strong the spirit of innovation is in this field,” said Stephanie Wieneke from SaxoCell.
A highlight of the event was an exclusive tour of the highly automated DKMS Life Science Lab, where participants gained fascinating insights into cutting-edge laboratory automation, serving as a model for future developments in cell and gene therapy.
“These are exactly the impulses we want to create with SaxoCell to drive the development of the cell and gene therapy sector in Saxony and across Germany,” emphasized SaxoCell. “The combination of scientific expertise and innovative automation solutions offers tremendous potential for growth and progress.”
The organizers announced that the next workshop is already being planned for early 2025. The focus remains on strengthening collaboration within the industry and promoting innovative solutions.
Breakthrough in the Treatment of Autoimmune Diseases with CD19 CAR-T Cell Therapy
A major advancement in medicine: for the first time, a novel CD19 CAR-T cell therapy has been successfully used to treat a patient with multi-refractory primary immune thrombocytopenia (ITP). This severe autoimmune disease causes the immune system to destroy platelets, leading to potentially life-threatening bleeding.
The innovative therapy achieved sustained remission in a patient who had exhausted all conventional treatments, including a splenectomy. By specifically eliminating harmful B cells responsible for producing autoantibodies, the CAR-T cell therapy not only normalized platelet levels but also alleviated symptoms and significantly improved the patient’s quality of life—with fewer side effects compared to cancer treatment.
This groundbreaking case study was recently published in The Lancet (January 2025) by a team led by SaxoCell spokesperson Prof. Martin Bornhäuser. The success was made possible through collaboration with Dimitrios Mougiakakis from Magdeburg, an expert in CAR-T therapy for autoimmune diseases, who managed cell collection and reinfusion, as well as Karolin Trautmann-Grill and Malte von Bonin from Dresden, who coordinated patient care and follow-up.
“We have successfully used this therapy in cancer treatment many times before. With the SaxoCell Cluster for Cell and Gene Therapy, we have the ideal conditions to apply our knowledge and expertise to other indications as well,” explains SaxoCell spokesperson Prof. Frank Buchholz. Despite these promising results, further clinical studies are necessary to evaluate the long-term safety and broader applicability of this therapy.
Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells – ScienceDirect
https://www.uniklinikum-dresden.de/de/presse/aktuelle-medien-informationen/durchbruch-bei-der-the rapie-von-autoimmunerkrankungen-car-t-zelltherapie-erstmals-erfolgreich-bei-der-primaeren-itp-angew endet
SaxoCell starts its second funding phase
The SaxoCell consortium kicked off the second funding phase with a successful meeting on January 20th and 21st, 2025, at Fraunhofer IZI in Leipzig. In an inspiring and productive gathering, the project teams exchanged ideas about their upcoming three years of research in the field of cell and gene therapy.
During both days, the teams presented their innovative ideas and plans for the further development of the current eight SaxoCell projects. A special highlight of the meeting was the involvement of the project sponsor, Jülich, who provided valuable insights and support for the ongoing implementation of the research projects.
Additionally, a creative Lego Serious Play® workshop, conducted by mikomi – the Institute for Small and Medium-Sized Enterprise Cooperation at the University of Mittweida, allowed participants to develop innovative solutions and strengthen collaboration within the consortium. Another highlight was the inspiring keynote by Prof. Andreas Zaby from the Federal Agency for Disruptive Innovations (SPRIND), which opened up new perspectives on groundbreaking innovations.
Advancing Genome Editing Towards Therapies – DG-GT Annual Meeting 2025 Recap
Dresden, March 10-11, 2025 – SaxoCell proudly participated in the DG-GT Theme Day 2025: Genome Editing Towards Therapies, held on March 10-11 at the German Hygiene Museum in Dresden. This high-profile event, organized in collaboration with the Deutsche Gesellschaft für Gentherapien (DG-GT), Technische Universität Dresden, SaxoCell, and the University Hospital Carl Gustav Carus Dresden, convened leading experts to discuss the latest breakthroughs in genome editing and their therapeutic potential.
Under the leadership of SaxoCell speaker Frank Buchholz and SaxoCell PI Zoltan Ivics, the conference provided a dynamic forum for addressing key topics, including CRISPR screening, advanced delivery technologies, clinical applications, and ethical considerations in genome editing. The exchange of knowledge and ideas further reinforced SaxoCell’s commitment to pioneering next-generation therapies for patients in need.
Link to the event: https://www.dg-gt.de/currentmeeting
German Biotechnology Days 2025 – SaxoCell Was There!
This week, SaxoCell was represented at the German Biotechnology Days (DBT) in Heidelberg (April 9–10), with Anette Bartsch and Cathleen Meerheim from Saxocellutions attending on our behalf.
The event featured two inspiring days full of exciting presentations and valuable networking opportunities. A special highlight was the strong contribution from our cluster spokeswoman, Prof. Dr. Ulrike Köhl, who brought SaxoCell’s vision to the stage.
Another key moment: the symbolic handover of the DBT baton to André Hofmann from biosaxony, marking the start of the countdown to DBT 2026 in Leipzig!
We at SaxoCell are proud and excited to welcome the biotech community to our home region next year.
LSX Leaders | London 2025 – SaxoCell at the Forefront of Life Sciences Innovation
Our transfer representative, Alexander Funkner, represented SaxoCell at the LSX Leaders Forum in London from April 28–30, 2025—one of Europe’s premier platforms for innovation, investment, and collaboration in the life sciences sector.
Under the motto “Accelerating European Life Sciences,” the forum brought together decision-makers, investors, and industry pioneers to explore emerging trends, pressing challenges, and the future of health innovation.
For SaxoCell, the conference provided valuable insights into:
A special highlight was the CEO Forum Day on April 28, which offered an exclusive environment for high-level exchange—an ideal platform to advance SaxoCell’s vision for a sustainable innovation and transfer culture.
Alongside compelling panels and keynotes, the forum also offered a chance for joyful reunions: Alexander reconnected with familiar faces from Wirtschaftsförderung Sachsen, leap up, and Apollo Health Ventures—a strong testament to Saxony’s dynamic presence and growing influence in the international life sciences arena.
Courage, Failure, and Real Talk: 2nd SaxoCell Fuck-Up Night at Cosmo Wissenschaftsforum
On April 30th, SaxoCell, in collaboration with Cluster4Future SEMECO, proudly hosted the second edition of the SaxoCell Fuck-Up Night at the Cosmo Wissenschaftsforum in Dresden.
The evening featured three courageous speakers: startup founders Jens Geißler from DIA42 and Jan Moritz Middeke from Cancilico, as well as hardware developer Alexander Gürbig from ConnCons. They took to the stage to share what is often left unsaid: the hard lessons, the unexpected setbacks, and the “not-so-glorious” moments of building a business.
Their stories were raw, honest, and inspiring – at times humorous, at times painful – but always authentic. Most importantly, they sparked real conversations and delivered valuable insights for everyone in attendance.
With curious questions, engaging discussions, and well-earned snacks and drinks, the night proved once again: failure isn’t the opposite of success – it’s part of the journey.
Let’s continue learning, failing forward, and shaping resilient innovation ecosystems together.
We were thrilled to be part of this year’s Swiss Biotech Day in Basel – one of Europe’s leading biotechnology conferences!
Representing SaxoCell, our colleague Stephanie Wieneke joined the event as part of the Saxony joint booth, highlighting the strength and innovation emerging from our region. It was a great opportunity to connect with fellow biotech professionals, explore new collaborations, and present SaxoCell’s vision for the future of cell and gene therapy.
We’re proud to contribute to shaping the future of biotech from the heart of Saxony.
SaxoCell returns from Munich after this year’s Clusters4Future experience exchange.
Over two days, the seven clusters from both the first and second rounds of the competition had the opportunity to network and exchange ideas on key topics like cluster management, sustainability, and industrial collaborations. Representing us were SaxoCell spokesperson Frank Buchholz, along with Maren Henneken and Stefanie Binder from the Hub team.
This year’s hosts were Munich-based clusters MCube and CNATM. In addition to their thematic focuses on mobility and nucleic acid therapies, Best Practices on cluster sustainability, such as those presented by BioRN, were shared. During the panel discussion, participants received valuable insights into attracting young talent and skilled professionals, as well as transitioning Clusters4Future to the second funding phase. An open dialogue with representatives from the BMBF and Projektträger Jülich rounded off the meeting.
As in the past two years, the annual exchange provided an ideal opportunity to gain new insights, learn from one another, and reconnect with long-standing contacts. We’re looking forward to next year!
SaxoCell is pleased to announce that it has been selected by the Federal Ministry of Education and Research (BMBF) and an independent expert jury for a second phase of funding in the Clusters4Future initiative.
We are very happy about this as it highlights the potential and achievements of SaxoCell, a pioneering cluster for innovative cell and gene therapies.
BMBF Clusters4Future press release
University Leipzig press release
SaxoCell returns from Munich after this year’s Clusters4Future experience exchange.
Over two days, the seven clusters from both the first and second rounds of the competition had the opportunity to network and exchange ideas on key topics like cluster management, sustainability, and industrial collaborations. Representing us were SaxoCell spokesperson Frank Buchholz, along with Maren Henneken and Stefanie Binder from the Hub team.
This year’s hosts were Munich-based clusters MCube and CNATM. In addition to their thematic focuses on mobility and nucleic acid therapies, Best Practices on cluster sustainability, such as those presented by BioRN, were shared. During the panel discussion, participants received valuable insights into attracting young talent and skilled professionals, as well as transitioning Clusters4Future to the second funding phase. An open dialogue with representatives from the BMBF and Projektträger Jülich rounded off the meeting.
As in the past two years, the annual exchange provided an ideal opportunity to gain new insights, learn from one another, and reconnect with long-standing contacts. We’re looking forward to next year!
SaxoCell is pleased to announce that it has been selected by the Federal Ministry of Education and Research (BMBF) and an independent expert jury for a second phase of funding in the Clusters4Future initiative.
We are very happy about this as it highlights the potential and achievements of SaxoCell, a pioneering cluster for innovative cell and gene therapies.
BMBF Clusters4Future press release
Once again this year in Dresden, science enthusiasts of all ages had the chance to get to know SaxoCell and learn about the latest advances in cell and gene therapy in discussions with our hub team.
Our tried-and-tested games and craft materials were available at our booth, including the colourful magnetic fishing game on CAR-T cell therapy and the entertaining immune cell quiz. We were delighted to welcome so many curious visitors at our stand!
The enthusiasm and curiosity of the visitors made the event truly special. Seeing so many people eager to learn about scientific advancements and participate in our activities was incredibly rewarding. We look forward to continuing this tradition and sharing more exciting developments at future events. Thank you to everyone who joined us and made the night unforgettable!
At the beginning of June, our two-day SaxoCell retreat was a resounding success, offering a perfect blend of productive discussions and engaging activities. PIs and scientists from our projects and platforms, members from the SaxoCell Hub as well as our Scientific Advisory Board representatives gathered at Congress Hotel Chemnitz.
Our agenda was packed with insightful discussions, innovative pitches, and a comprehensive outlook on our future projects and perspectives.
The highlight of our retreat was the team challenge, where we formed eight teams to build spaghetti towers – aiming for the highest – fostering creativity and teamwork. The winning tower measured 70 centimetres! There was also a winner of hearts which was not as high but very stable and ready long before the end of the challenge.
Our SaxoCell Retreat 2024 not only strengthened our professional bonds but also provided valuable insights and renewed enthusiasm for our collective goals. Thank you to everyone who was part of this event! It was great to get to know each other apart from desk and bench!
SaxoCell returns from Munich after this year’s Clusters4Future experience exchange.
Over two days, the seven clusters from both the first and second rounds of the competition had the opportunity to network and exchange ideas on key topics like cluster management, sustainability, and industrial collaborations. Representing us were SaxoCell spokesperson Frank Buchholz, along with Maren Henneken and Stefanie Binder from the Hub team.
This year’s hosts were Munich-based clusters MCube and CNATM. In addition to their thematic focuses on mobility and nucleic acid therapies, Best Practices on cluster sustainability, such as those presented by BioRN, were shared. During the panel discussion, participants received valuable insights into attracting young talent and skilled professionals, as well as transitioning Clusters4Future to the second funding phase. An open dialogue with representatives from the BMBF and Projektträger Jülich rounded off the meeting.
As in the past two years, the annual exchange provided an ideal opportunity to gain new insights, learn from one another, and reconnect with long-standing contacts. We’re looking forward to next year!
SaxoCell Retreat 2024
Unser zweitägiger SaxoCell-Retreat Anfang Juni war ein voller Erfolg und bot eine perfekte Mischung aus konstruktiven Diskussionen und spannenden Aktivitäten. Projektleitende und Forschende aus unseren Projekten und Plattformen, Mitglieder des SaxoCell-Hubs sowie Vertreter:innen unseres wissenschaftlichen Beirats kamen im Congress Hotel Chemnitz zusammen
Auf unserer Agenda standen aufschlussreiche Diskussionen, innovative Pitches und ein umfassender Ausblick auf unsere zukünftigen Projekte.
Den Höhepunkt des Retreats bildete die Team-Challenge, bei der wir acht Teams bildeten, um Spaghetti-Türme zu bauen – mit dem Ziel, den höchsten Turm zu erreichen – und so Kreativität und Teamwork zu fördern. Der Siegerturm war 70 Zentimeter hoch! Es gab auch einen Sieger der Herzen, der nicht so hoch, aber sehr stabil war und lange vor dem Ende der Zeitnahme stand.
Unser SaxoCell Retreat 2024 hat nicht nur unsere berufliche Verbundenheit gestärkt, sondern auch wertvolle Einblicke und neue Begeisterung für unsere gemeinsamen Ziele generiert. Vielen Dank an alle, die an dieser Veranstaltung teilgenommen haben! Es war großartig, sich abseits von Schreibtisch und Labortisch kennenzulernen!
Auch in diesem Jahr hatten Wissenschaftsinteressierte jeden Alters in Dresden die Chance, SaxoCell kennenzulernen und die neuesten Fortschritte in der Zell- und Gentherapie in Gesprächen mit unserem Hub-Team zu erfahren.
Am Stand durften auch wieder unsere bewährten Spiel- und Bastelmaterialien ausprobiert werden, u.a das bunte Magnetspiel zur CAR-T-Zelltherapie und das unterhaltsame Immunzell-Quiz. Wir waren begeistert über die wieder so zahlreich erschienenen neugierigen Besucher!
Enthusiasmus und Neugierde der Besucher machten die Veranstaltung zu etwas ganz Besonderem. Es war unglaublich bereichernd, so viele Menschen zu sehen, die sich über wissenschaftliche Fortschritte informieren und an unseren Aktivitäten teilnehmen wollten. Wir werden diese Tradition fortsetzen und bei künftigen Veranstaltungen weitere spannende Entwicklungen präsentieren. Vielen Dank an alle, die dabei waren und diesen Abend unvergesslich gemacht haben!
SaxoCell kehrt begeistert zurück aus München vom diesjährigen Erfahrungsaustausch der Zukunftscluster.
An zwei Tagen hatten die sieben Cluster der ersten sowie die sieben Cluster der zweiten Wettbewerbsrunde die Möglichkeit, sich untereinander zu vernetzen und zu wesentlichen Themen wie Clustermanagement, Verstetigung und Industriekooperationen auszutauschen. Mit dabei waren unser SaxoCell-Sprecher Frank Buchholz sowie Maren Henneken und Stefanie Binder vom Hub-Team.
Gastgeber in diesem Jahr waren die beiden Münchner Cluster MCube und CNATM. Neben thematischen Schwerpunkten Mobilität und Nukleinsäuretherapien wurden Best Practices zur Clusterverstetigung, etwa von BioRN, vorgestellt. In der Paneldiskussion erhielten die Teilnehmenden wertvolle Impulse zur Nachwuchs- und Fachkräftegewinnung sowie zum Transfer der Zukunftscluster in die zweite Förderphase. Ein offener Austausch mit dem BMBF und dem Projektträger Jülich rundete das Meeting ab.
Wie in den beiden Jahren zuvor, bot auch dieser Erfahrungsaustausch eine ideale Gelegenheit, neue Eindrücke zu gewinnen, voneinander zu lernen und alte Kontakte aufzufrischen. Wir freuen uns auf das Treffen im nächsten Jahr!
SaxoCell wurde vom Bundesministerium für Bildung und Forschung (BMBF) und einer unabhängigen Fachjury für die zweite Förderphase im Clusters4Future-Wettbewerb ausgewählt!
Wir freuen uns sehr, denn diese Entscheidung unterstreicht das enorme Potenzial und die bisherigen Erfolge unseres Clusters für innovative Zell- und Gentherapien.
Pressemeldung BMBF Clusters4Future
Pressemitteilung der TU Dresden
You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/